SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001178913-13-000068
Filing Date
2013-01-08
Accepted
2013-01-08 08:52:36
Documents
1
Group Members
CLAL INDUSTRIES & INVESTMENTS LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A zk1312486.htm SC 13D/A 96991
  Complete submission text file 0001178913-13-000068.txt   98525
Mailing Address 3AZRIELI CENTER TRIANGLE TOWER 45 FLOOR TEL AVIV L3 67023
Business Address 3AZRIELI CENTER TRIANGLE TOWER 45 FLOOR TEL AVIV L3 67023 972-3-6075794
Clal Biotechnology Industries Ltd. (Filed by) CIK: 0001468950 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 8 HARTOM ST., 3RD FLOOR, JERUSALEM L3 97775
Business Address 8 HARTOM ST., 3RD FLOOR, JERUSALEM L3 97775 972-2-5486555
BioCancell Ltd. (Subject) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1211
Type: SC 13D/A | Act: 34 | File No.: 005-86953 | Film No.: 13516687
SIC: 2834 Pharmaceutical Preparations